2024-12-26 22:12:28
Everest Medicines to Hold New Corporate Strategy Online Conference Calls
Corporate/ 2023-07-24
Everest Medicines to Hold New Corporate ...

SHANGHAI,Dec. 30,2022--Everest Medicines (HKEX: 1952),a biopharmaceutical company focused on the development,manufacturing and commercializa...

Everest Medicines Announces China NMPA Recommends Priority Review for Nefecon for the Treatment of Primary IgA Nephropathy
Corporate/ 2023-07-24
Everest Medicines Announces China NMPA R...

--Further regulatory support for accelerated approval of Nefecon following NMPA\'s NDA acceptance with Breakthrough Therapy Designation—

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release